| 
MechanismPLA2G10 inhibitors   | 
Active Org.-  | 
 | 
Active Indication-  | 
 | 
Drug Highest PhaseDiscontinued  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
 | 
 | 
Active Org.-  | 
 | 
Active Indication-  | 
 | 
Drug Highest PhasePending  | 
First Approval Ctry. / Loc.-  | 
First Approval Date-  | 
100 Clinical Results associated with CS Astra Ltd.
0  Patents (Medical) associated with CS Astra Ltd.
100 Deals associated with CS Astra Ltd.
100 Translational Medicine associated with CS Astra Ltd.